![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 2, 1041-1050, January 12, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Section on Chemical Immunology, Arthritis and Rheumatism
Branch, NIAMS, National Institutes of Health,
Bethesda, Maryland 20892-1820
Chinese hamster ovary fibroblasts previously
transfected with the high affinity receptor for IgE (Fc
Interaction between the Unphosphorylated Receptor with High
Affinity for IgE and Lyn Kinase*
§,
,
RI) were
further transfected with the
subunit of the receptor for
interleukin 2 (Tac) or with chimeric constructs in which the
cytoplasmic domain of Tac was replaced with the C-terminal cytoplasmic
domain of either the
subunit or the
subunit of Fc
RI. Whereas
native Tac failed to affect the aggregation-induced phosphorylation of
Fc
RI, both chimeric constructs substantially inhibited this
reaction. Alternatively, the Fc
RI-bearing fibroblasts were
transfected with two chimeric constructs in which the cytoplasmic
domain of Tac was replaced with a modified short form of Lyn kinase.
The Lyn in both of the chimeric constructs had been mutated to remove
the sites that are normally myristoylated and palmitoylated,
respectively; one of the constructs had in addition been altered to be
catalytically inactive. The catalytically active construct enhanced,
and the inactive construct inhibited, aggregation-induced
phosphorylation of the receptors. All of the chimeric constructs were
largely distributed outside the detergent resistant microdomains, and whereas aggregation caused them to move to the domains in part, their
aggregation was neither necessary nor enhanced their effects. These
results and others indicate that the receptor and Lyn interact through
protein-protein interactions that neither are dependent upon either the
post-translational modification of the kinase with lipid moieties nor
result exclusively from their co-localization in specialized membrane domains.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
These authors contributed equally to this work.
§
Present address: Allergy and Clinical Immunology Division, John
Hopkins Asthma and Allergy Center, 5501 Hopkins Bayview Circle, Baltimore, MD 21224-6108.
¶
Present address: 16 Franklin Woods Dr., Somers, CT 06071.
To whom correspondence should be addressed: Bldg. 10, Rm.
9N-228, 10 Center Dr., MSC-1820, NIAMS, NIH, Bethesda, MD 20892-1820. Tel.: 301-435-6126; Fax: 301-402-0012; E-mail:
metzgerh@exchange.nih.gov.
This article has been cited by other articles:
![]() |
C. M. Udell, L. A. Samayawardhena, Y. Kawakami, T. Kawakami, and A. W. B. Craig Fer and Fps/Fes Participate in a Lyn-dependent Pathway from Fc{epsilon}RI to Platelet-Endothelial Cell Adhesion Molecule 1 to Limit Mast Cell Activation J. Biol. Chem., July 28, 2006; 281(30): 20949 - 20957. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kovarova, C. A. Wassif, S. Odom, K. Liao, F. D. Porter, and J. Rivera Cholesterol deficiency in a mouse model of Smith-Lemli-Opitz syndrome reveals increased mast cell responsiveness J. Exp. Med., May 15, 2006; 203(5): 1161 - 1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Young, X. Zheng, D. Holowka, and B. Baird Reconstitution of Regulated Phosphorylation of Fc{epsilon}RI by a Lipid Raft-excluded Protein-tyrosine Phosphatase J. Biol. Chem., January 14, 2005; 280(2): 1230 - 1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Furumoto, S. Nunomura, T. Terada, J. Rivera, and C. Ra The Fc{epsilon}RI{beta} Immunoreceptor Tyrosine-based Activation Motif Exerts Inhibitory Control on MAPK and I{kappa}B Kinase Phosphorylation and Mast Cell Cytokine Production J. Biol. Chem., November 19, 2004; 279(47): 49177 - 49187. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. On, J. M. Billingsley, M.-H. Jouvin, and J.-P. Kinet Molecular Dissection of the FcR{beta} Signaling Amplifier J. Biol. Chem., October 29, 2004; 279(44): 45782 - 45790. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Young, D. Holowka, and B. Baird A Lipid Raft Environment Enhances Lyn Kinase Activity by Protecting the Active Site Tyrosine from Dephosphorylation J. Biol. Chem., May 30, 2003; 278(23): 20746 - 20752. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Faeder, W. S. Hlavacek, I. Reischl, M. L. Blinov, H. Metzger, A. Redondo, C. Wofsy, and B. Goldstein Investigation of Early Events in Fc{epsilon}RI-Mediated Signaling Using a Detailed Mathematical Model J. Immunol., April 1, 2003; 170(7): 3769 - 3781. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Eglite, J. M. Morin, and H. Metzger Synthesis and Secretion of Monocyte Chemotactic Protein-1 Stimulated by the High Affinity Receptor for IgE J. Immunol., March 1, 2003; 170(5): 2680 - 2687. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. B. Craig and P. A. Greer Fer Kinase Is Required for Sustained p38 Kinase Activation and Maximal Chemotaxis of Activated Mast Cells Mol. Cell. Biol., September 15, 2002; 22(18): 6363 - 6374. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Tolar, R. Arudchandran, L. Draberova, J. Rivera, and P. Draber Structure-Function Analysis of Lyn Kinase Association with Lipid Rafts and Initiation of Early Signaling Events after Fcvarepsilon Receptor I Aggregation Mol. Cell. Biol., December 15, 2001; 21(24): 8318 - 8328. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |